Some of the interesting studies suggest that you can potentially give, for instance, parkinson's diseased patients whose adopminurgic na have largely died off. So there's some really exciting treatment on the horizon. But wouldn't dismiss plain old whatever, small molecules and large molecule therapeutics. Some of the biggest advances in treating disease have come from taking those traditional tools and applying them in a much more intelligent way....